Skip to content

    UPL Q1 FY27 earnings call

    UPL
    Chemicals·3 Aug 2026
    Management Summary

    UPL Limited delivered a resilient Q1 FY27 performance, achieving its seventh consecutive quarter of revenue and EBITDA growth with a 10% increase in revenue to ₹10,181 crores and a 15% rise in EBITDA to ₹1,500 crores. PATMI turned positive for the first time in three years. Despite macroeconomic headwinds like geopolitical uncertainties and adverse weather impacting volumes, strategic pricing actions and strong performance in Seeds and Super Specialty Chemicals contributed to growth. The company also made progress on deleveraging, reducing gross debt and improving its net debt-to-EBITDA ratio.

    Highlights

    5

    • Revenue of ₹10,181 crores, up 10% YoY, driven by 3% positive pricing and favorable exchange impact.

    • EBITDA grew 15% to ₹1,500 crores, with EBITDA margin expanding 60 bps to 14.7%, marking the seventh consecutive quarter of revenue and EBITDA growth.

    • PATMI turned positive at ₹10 crores, a significant improvement from a negative ₹88 crores last year, driven by lower net finance cost and favorable net exchange difference.

    • Gross debt reduced by over $100 million from $3.1 billion to $3.0 billion, and net debt-to-EBITDA improved to 2.4x from 2.6x.

    • Strong volume growth in Seeds and Super Specialty Chemicals businesses, offsetting declines in other segments.

    Concerns

    3

    • Overall volumes declined by 3%, primarily due to severe weather-led delays and heat wave conditions in Europe and Latin America.

    • El Niño led to planting delays in parts of India and Europe, phasing some demand into later quarters.

    • Net working capital increased to 110 days, up 24 days versus last June, due to higher inventory and receivables.

    Key financials

    Single quarter

    10 metrics
    1. 01Revenue₹10,181 Cr+10%YoY
    2. 02Contribution₹4,607 Cr+15%YoY
    3. 03Contribution Margin45.2%
    4. 04EBITDA₹1,500 Cr+15%YoY
    5. 05EBITDA Margin14.7%

    Segment breakdown

    UPL Corp (Global Crop Protection)
    ₹6,374 Cr Revenue7.0% Revenue Growth₹532 Cr EBITDA38% EBITDA Growth190 bps EBITDA Margin Expansion
    UPL SAS (India Crop Protection)
    — Revenue Growth34% EBITDA Growth750 bps EBITDA Margin Expansion30% EBITDA Margin
    Advanta (Seeds and Post-Harvest)
    26% Revenue Growth24% EBITDA Growth
    SUPERFORM (Manufacturing and Super Specialty Chemicals)
    14.0% Revenue Growth51% Specialty Chemicals Growth17% Specialty Chemicals Volume Growth34% Specialty Chemicals Price Growth7.0% EBITDA Growth71% Ag Revenue Share29% Super Specialty Revenue Share
    North America
    18% Revenue Growth
    India
    15% Revenue Growth
    Latin America
    8% Revenue Growth
    Europe
    4% Revenue Growth
    Rest of the World
    7.0% Revenue Growth
    List

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Gross USD 3 billion · 2.4x EBITDA

    M&A

    Sinova

    acquisition · integrated · Consideration ₹NaN (undisclosed)

    Liquidity

    Undrawn USD 2.3 billion

    Includes $300 million committed RCF line and $2 billion of uncommitted working capital lines. Management is comfortable meeting December 2026 obligations with internal cash flows and existing liquidity.

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    Full Year Revenue Growth
    7% to 11%
    		High
    Profitability
    Full Year EBITDA Growth
    10% to 14%
    		High
    Profitability
    India Crop Protection EBITDA Margin
    materially higher than last year
    		Medium
    Debt
    Net Debt to EBITDA
    less than 1.5x
    		High
    New Product Launches
    Revenue from New Product Launches
    $115 million
    		High
    NPP Brands
    Revenue from NPP Brands
    $700 million
    		High
    Product Mix
    SUPERFORM Ag vs. Super Specialty Mix
    55% ag and 45% super specialty
    		Medium

    What to watch in Q2 FY27

    5

    Global Crop Protection Volume Growth

    FY27
    Current-3% in Q1 FY27
    TargetFlat to slightly up YoY for FY27

    Why it matters

    Volume growth is crucial for overall revenue expansion beyond pricing, especially given Q1's decline.

    we will see the global demand for the crop protection products that we're in the business of, flat to slightly up on a year-over-year basis.

    Risks & concerns

    4
    RiskSeverity

    Geopolitical Uncertainties (West Asia conflict)

    Ongoing conflict in West Asia keeps input costs and supply chain volatility elevated, though managed proactively through diversified sourcing. — Management acknowledged

    high

    Weather-led Planting Delays (El Niño)

    El Niño led to planting delays in India, US, and Europe, phasing demand and impacting Q1 volumes, leading to caution on agrochemicals outlook. — Management acknowledged

    medium

    Persistent Farm Income Stress

    Farm income stress in several key geographies leads growers to be cautious in purchasing decisions. — Management acknowledged

    medium

    Channel Inventory Management

    Management is guiding channels to be cautious on building inventory to avoid oversupply issues experienced in FY24, leading to 'just-in-time' buying. — Management acknowledged

    medium

    Q&A highlights

    8

    “for the rest of the quarters, we have considered constant currency. So whatever the currency rate is there for end of June, the same has been considered. We have not considered any appreciation or depreciation in the currency and basis that we have come up with the guidance. ... we will see the global demand for the crop protection products that we're in the business of, flat to slightly up on a year-over-year basis.”

    Analyst sought clarity on the drivers of full-year guidance, particularly the contribution of volume, pricing, and currency, given Q1's forex gains. Management clarified constant currency assumption for future quarters and indicated flat to slightly up global volume.

    asked by Saurabh Jain (HSBC)

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Q1 FY27 Performance Amidst Macro Headwinds

    UPL Limited delivered a robust Q1 FY27, marking its seventh consecutive quarter of revenue and EBITDA growth. Revenue increased by 10% to ₹10,181 crores, driven by 3% positive pricing and favorable exchange rates, despite a 3% decline in volumes. EBITDA grew 15% to ₹1,500 crores, with margins expanding 60 bps to 14.7%. PATMI turned positive at ₹10 crores, a significant improvement from a negative ₹88 crores in the prior year, attributed to lower net finance costs and favorable net exchange differences.

    02

    Strategic Focus on Profitability and Deleveraging

    The company emphasized its focus on profitable growth, disciplined execution, and robust governance, which led to a 100 bps expansion in contribution margin to 45.2%. Gross debt was reduced by over $100 million from $3.1 billion to $3.0 billion, and the net debt-to-EBITDA ratio improved to 2.4x from 2.6x, with the deleveraging trajectory remaining intact. Management reiterated its medium-term target of less than 1.5x net debt-to-EBITDA, underscoring its commitment to financial discipline.

    03

    Segmental and Regional Growth Dynamics

    Growth was broad-based across platforms and regions. Advanta (seeds and post-harvest) saw strong revenue growth of 26% and EBITDA growth of 24%. SUPERFORM's specialty chemicals business surged 51%, driven by 17% volume and 34% price growth, contributing to a 14% overall growth for the segment. Regionally, North America grew 18%, India 15%, Latin America 8%, Europe 4%, and Rest of World 7%, demonstrating the value of a diversified geographic footprint.

    04

    Navigating Macroeconomic Challenges

    UPL operated amidst continued volatility from the West Asia conflict, which elevated input costs and supply chain volatility🌐, though managed proactively. Weather-led planting delays due to El Niño in India, the U.S., and Europe led to volume softness, but this was partially offset by strong volume growth in Seeds and Super Specialty Chemicals. Management proactively adjusted pricing to mitigate cost increases and guided channels to manage inventory cautiously, learning from past oversupply issues.

    05

    Strategic Initiatives and Outlook

    The company received SEBI approval for the Advanta IPO and CCI approval for the Crop Protection business reorganization, aiming for a single focused global crop protection platform. CareEdge upgraded UPL's long-term rating to CARE AA+, reflecting strengthened credit profile. For FY27, UPL guided for revenue growth of 7-11% and EBITDA growth of 10-14%, expecting a strong volume-led second quarter and $115 million in revenue from new product launches, while remaining cautious on the agrochemicals segment outlook.

    06

    Leadership Transition in UPL Corp

    Mike Frank, CEO of UPL Corp, announced his decision to step down after 4.5 years to relocate to the United States. Management expressed gratitude for his invaluable contributions to the company's transformation journey and strengthening of its global crop protection business, highlighting his role in advancing innovation, customer centricity, and operational excellence. The company affirmed that the business remains well-positioned with a strong leadership team for continued growth.

    This is an AI-generated summary of a publicly available earnings call transcript.